These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 4708457)

  • 21. Preanesthetic investigation of malignant hyperthermia: microscopy.
    Harriman DG
    Int Anesthesiol Clin; 1979; 17(4):97-117. PubMed ID: 521181
    [No Abstract]   [Full Text] [Related]  

  • 22. Fingerprint body myopathy, a newly recognized congenital muscle disease.
    Engel AG; Angelini C; Gomez MR
    Mayo Clin Proc; 1972 Jun; 47(6):377-88. PubMed ID: 4339422
    [No Abstract]   [Full Text] [Related]  

  • 23. Malignant hyperpyrexia.
    Stephen CR
    Annu Rev Med; 1977; 28():153-7. PubMed ID: 324354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Histological, histochemical, and ultrastructural findings in malignant hyperthermia (author's transl)].
    Gullotta F; Helpap B
    Virchows Arch A Pathol Anat Histol; 1975 Aug; 367(3):181-94. PubMed ID: 808899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Anesthesia incident: malignant hyperthermia (case report)].
    Ehehalt V; Burmeister G; Sauer H
    Z Laryngol Rhinol Otol; 1973 Mar; 52(3):167-9. PubMed ID: 4698066
    [No Abstract]   [Full Text] [Related]  

  • 26. Abnormal creatine-phosphokinase isoenzyme pattern in families with malignant hyperpyrexia.
    Zsigmond EK; Starkweather WH; Duboff GS; Flynn KA
    Anesth Analg; 1972; 51(5):827-40. PubMed ID: 4672179
    [No Abstract]   [Full Text] [Related]  

  • 27. Elevated serum-creatine phosphokinase activity in a family with malignant hyperpyrexia.
    Zsigmond EK; Starkweather WH; Duboff GS; Flynn K
    Anesth Analg; 1972; 51(2):220-5. PubMed ID: 5062123
    [No Abstract]   [Full Text] [Related]  

  • 28. Central core disease associated with elevated creatine phosphokinase levels. Two members of a family known to be susceptible to malignant hyperpyrexia.
    Isaacs H; Barlow MB
    S Afr Med J; 1974 Mar; 48(15):640-2. PubMed ID: 4823722
    [No Abstract]   [Full Text] [Related]  

  • 29. [A genetic muscular creatine phosphokinase abnormality in a family with malignant hyperpyrexia].
    Zsigmond EK; Starkweather WH; Duboff GS; Flyn K
    Rev Bras Anestesiol; 1971; 21(3):265-76. PubMed ID: 5138487
    [No Abstract]   [Full Text] [Related]  

  • 30. [X-linked myotubular myopathy].
    Il'ina NA; Aver'ianov IuN; Potomskaia LZ; Ivanchenko OV; Biriukov VB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(10):1334-8. PubMed ID: 573945
    [No Abstract]   [Full Text] [Related]  

  • 31. Isoenzymes of creatine phosphokinase in serum of families with malignant hyperpyrexia.
    Meltzer HY; Hassan SZ; Russo P; Cho HW
    Anesth Analg; 1976; 55(6):797-9. PubMed ID: 1033694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Two cases of subclinical myopathy. Is it a trait for malignant hyperthermia? (author's transl)].
    Sunohara N; Takagi A; Nonaka I; Satoyoshi E; Kojima S
    Rinsho Shinkeigaku; 1980 Jun; 20(6):448-54. PubMed ID: 7408344
    [No Abstract]   [Full Text] [Related]  

  • 33. The association of malignant hyperthermia and unusual disease: when you're hot you're hot or maybe not.
    Davis PJ; Brandom BW
    Anesth Analg; 2009 Oct; 109(4):1001-3. PubMed ID: 19762721
    [No Abstract]   [Full Text] [Related]  

  • 34. Creatine phosphokinase (CPK) levels in pregnancy: a case report and a discussion of the value of CPK levels in the prediction of possible malignant hyperpyrexia.
    Isherwood DM; Ridley J; Wilson J
    Br J Obstet Gynaecol; 1975 Apr; 82(4):346-9. PubMed ID: 1125158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Malignant hyperthermia--postoperative changes of serum LDH and CPK isozymes (author's transl)].
    Shimonaka H; Yamamoto M
    Masui; 1981 Feb; 30(2):141-9. PubMed ID: 7277676
    [No Abstract]   [Full Text] [Related]  

  • 36. [Malignant hyperthermia].
    Popinigis J; Brucker RF; Taylor CA; Williams CH
    Pol Tyg Lek; 1972 Aug; 27(33):1290-3. PubMed ID: 4562245
    [No Abstract]   [Full Text] [Related]  

  • 37. [Muscular enzyme level disorders and a malignant hyperthermia susceptability test: postoperative study of a patient with elevated CPK].
    Perugini M; Montironi C; Rocchi S
    Minerva Anestesiol; 1998; 64(1-2):45-50. PubMed ID: 9658790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Muscle changes in malignant hyperthermia.
    Hausman R
    J Pathol; 1973 Jul; 110(3):Pv-vi. PubMed ID: 4744080
    [No Abstract]   [Full Text] [Related]  

  • 39. [Malignant hyperthermia during an operation (a review of the literature)].
    Chernokozhev Kh
    Khirurgiia (Sofiia); 1976; 29(1):64-9. PubMed ID: 772294
    [No Abstract]   [Full Text] [Related]  

  • 40. Histological, histochemical and ultramicroscopic findings in muscle biopsies from carriers of the trait for malignant hyperpyrexia.
    Isaacs H; Frere G; Mitchell J
    Br J Anaesth; 1973 Aug; 45(8):860-8. PubMed ID: 4753682
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.